Country: Հարավաֆրիկյան Հանրապետություն
language: անգլերեն
source: South African Health Products Regulatory Authority (SAHPRA)
Schering
NERISONE SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): NERISONE CREAM, OINTMENT, FATTY OINTMENT Corticoid skin preparations COMPOSITION 1 g Nerisone contains diflucortolone valerate (6alpha,9-difluoro-11beta-hydroxy-21-valeryloxy-16alpha-methyl-1,4- pregnadiene-3,20-dione) 1 mg. The cream contains methylparaben 0,07% and propylparaben 0,03%. PHARMACOLOGICAL CLASSIFICATION A. 13.4.1 Corticosteroids without anti-infective agents. PHARMACOLOGICAL ACTION Diflucortolone valerate is an effective corticoid. On topical application it suppresses inflammation in inflammatory and allergic skin conditions and ameliorates the subjective complaints, such as itching, burning and pain. Diflucortolone valerate is incorporated in three bases formulated to suit the respective skin condition. INDICATIONS All skin diseases which respond to topical corticoid therapy, eg contact dermatitis, contact eczema, occupational eczema; vulgar, nummular (microbial), degenerative and seborrhoeic eczema; dyshidrotic eczema; eczema in varicose syndrome (excluding ulcers); anal eczema; eczema in children; neurodermatitis (endogenous eczema, atopic dermatitis); psoriasis; lichen ruber planus et verrucosus; lupus erythematosus; first degree burns, sunburn, insect bites. CONTRA-INDICATIONS Tuberculous and syphilitic processes in the area to be treated, virus diseases (herpes simplex, vaccinia, varicella and smallpox). Potent topical corticosteroid preparations (Nerisone) should not be applied to any skin crease areas. Corticosteroids have been shown to be teratogenic in animals following dermal application. As these agents are absorbed percutaneously, teratogenicity following topical application cannot be excluded. Therefore Nerisone should not be used during pregnancy. DOSAGE AND DIRECTIONS FOR USE Unless otherwise prescribed by the doctor, the Neri read_full_document